NIPPON CHEMIPHAR CO.,LTD. (4539.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

40.4x

EV/EBITDA

11.7x

Market Cap

JPY 5.67B

MomentumView details →

1D Return

−1.94%

YTD Return

−0.95%

RSI (14)

44.9

ValuationView details →

P/E (Fwd)

40.4x

EV/EBITDA

11.7x

Market Cap

JPY 5.67B

RSI (14)

44.9

MomentumView details →

1D Return

−1.94%

YTD Return

−0.95%

ProfitabilityView details →

Gross Margin

26.89%

Net Margin

1.68%

EBITDA Margin

6.10%

ROE (TTM)

2.83%

ROA (TTM)

1.05%

Asset Turnover

0.62x

GrowthView details →

Revenue YoY

+1.67%

EPS YoY

+318.90%

FCF YoY

—

Revenue CAGR 3Y

+0.07%

EPS CAGR 3Y

−25.08%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.69x

Current Ratio

2.28x

Quick Ratio

1.77x

Div Yield

3.19%

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

32.52B

Net Income (TTM)

545.00M

Op. CF (TTM)

—

Next earningsNov 4, 2026 →

Latest newsMore news →

No recent news for 4539.T.

Similar companies

Chiome Bioscience Inc.4583.T BrightPath Biotherapeutics Co.,Ltd.4594.T Cyfuse Biomedical K.K.4892.T J-Pharma Co.,Ltd.520A.T Noile-Immune Biotech Inc.4893.T PRISM BioLab Co.,LTD206A.T Find similar companies →

Latest newsMore news →

No recent news for 4539.T.